IONS- Ionis Pharmaceuticals, Inc.

Name: Ionis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. IONS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Monia Brett P	260.3K	$19.78M	-
VP	Bennett C Frank	100.3K	$7.62M	-
CFO	Hougen Elizabeth L	82.7K	$6.28M	-
VP	Schneider Eugene	69.7K	$5.30M	-
VP	Birchler Brian	67.5K	$5.13M	-973

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 16, 2026	Birchler Brian49	EVP, Corp And Development Ops	Sale+OE	973	$75.04	$73,015.87	-1.4%	-	-
Apr 16, 2026	Jenne Kyle	EVP, Chf Gl Pdt Str Ofcr	Sale+OE	4,902	$75.17	$368,488.24	-17.1%	-	-
Apr 16, 2026	Baroldi Joseph51	EVP, Chief Business Officer	Sale+OE	5,619	$74.56	$418,952.64	-10.8%	-	-
Apr 15, 2026	Parshall B Lynne74	Director	Sell	5,000	$76.27	$381,366.52	-4.6%	-	-
Mar 17, 2026	Hougen Elizabeth L51	EVP, Finance &CFO	Sale+OE	225,220	$72.43	$16,313,675.85	-44.8%	-	-
Mar 10, 2026	Jenne Kyle	EVP, Chf Gl Pdt Str Ofcr	Sale+OE	37,277	$75.85	$2,827,324.68	-48.5%	-	-
Mar 10, 2026	Monia Brett P60	Chief Executive Officer	Sale+OE	160,773	$75.35	$12,114,155.20	-10.6%	-	-
Mar 9, 2026	O'Neil Patrick R.56	EVP CLO &General Counsel	Sell	10,148	$75.25	$763,662.37	-14.0%	-	-
Jan 30, 2026	Swayze Eric63	EVP Research	Sell	6,179	$82.93	$512,446.10	-11.5%	-9.6%	-
Jan 30, 2026	O'Neil Patrick R.56	EVP CLO &General Counsel	Sell	6,179	$83.53	$516,153.50	-7.9%	-9.6%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC